Daiken Medical Co., Ltd. (7775.T)
JPY 513.0
(-0.58%)
JPY 513.0
(-0.58%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 9.75 Billion | 9.13 Billion | 8.54 Billion | 7.86 Billion | 8.52 Billion | 8.4 Billion |
| Cost of Revenue | 5.81 Billion | 5.6 Billion | 4.85 Billion | 4.5 Billion | 4.78 Billion | 4.46 Billion |
| Gross Profit | 3.93 Billion | 3.53 Billion | 3.68 Billion | 3.35 Billion | 3.73 Billion | 3.93 Billion |
| Operating Expenses | 2.53 Billion | 2.47 Billion | 2.53 Billion | 2.43 Billion | 2.53 Billion | 2.68 Billion |
| Selling, General and Administrative Expenses | 2.23 Billion | 2.1 Billion | 2.09 Billion | 1.94 Billion | 2.01 Billion | 2.12 Billion |
| Research and Development Expenses | 249 Million | 316 Million | 382 Million | 448 Million | 488 Million | 512 Million |
| Other Expenses | - | 2.67 Million | 4.06 Million | 39.81 Million | 20.25 Million | 1.02 Million |
| Cost and Expenses | 8.3 Billion | 8.08 Billion | 7.38 Billion | 6.94 Billion | 7.32 Billion | 7.15 Billion |
| Operating Income | 1.44 Billion | 1.05 Billion | 1.15 Billion | 921.21 Million | 1.19 Billion | 1.24 Billion |
| Interest Expense | 4.82 Million | 3.96 Million | 3.73 Million | 3.8 Million | 4.55 Million | 4.76 Million |
| Income Tax Expense | 447.85 Million | 312.96 Million | 320.28 Million | 269.51 Million | 331.56 Million | 302.07 Million |
| Earnings before Tax | 1.43 Billion | 1.02 Billion | 1.15 Billion | 944.75 Million | 1.19 Billion | 1.15 Billion |
| Net Income | 988.6 Million | 712.06 Million | 831.05 Million | 675.23 Million | 859.54 Million | 851.6 Million |
| Earnings Per Share Basic | 34.41 | 24.79 | 28.93 | 23.50 | 29.92 | 29.05 |
| Earnings Per Share Diluted | 34.41 | 24.79 | 28.93 | 23.50 | 29.92 | 29.05 |
| Weighted Average Shares Outstanding | 28.72 Million | 28.72 Million | 28.72 Million | 28.72 Million | 28.72 Million | 29.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.72 Million | 28.72 Million | 28.72 Million | 28.72 Million | 28.72 Million | 29.31 Million |
| Gross Margin | 0.40 | 0.39 | 0.43 | 0.43 | 0.44 | 0.47 |
| EBIT Margin | 0.17 | 0.15 | 0.17 | 0.15 | 0.17 | 0.18 |
| Profit Margin | 0.10 | 0.08 | 0.10 | 0.09 | 0.10 | 0.10 |
| EBITDA | 1.65 Billion | 1.29 Billion | 1.47 Billion | 1.18 Billion | 1.45 Billion | 1.46 Billion |
| Earnings Before Tax Margin | 0.15 | 0.12 | 0.13 | 0.12 | 0.14 | 0.15 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.51 Billion | 2.39 Billion | 9.75 Billion | 2.34 Billion | 2.58 Billion | 2.46 Billion |
| Cost of Revenue | 1.45 Billion | 1.38 Billion | 5.81 Billion | 1.43 Billion | 1.49 Billion | 1.42 Billion |
| Gross Profit | 1.06 Billion | 1.01 Billion | 3.93 Billion | 904.42 Million | 1.08 Billion | 1.03 Billion |
| Operating Expenses | 624.67 Million | 615 Million | 2.48 Billion | 699.21 Million | 592.13 Million | 629.15 Million |
| Selling, General and Administrative Expenses | 624.67 Million | 616 Million | - | 630.21 Million | 536.13 Million | 567.15 Million |
| Research and Development Expenses | - | - | - | 69 Million | 56 Million | 62 Million |
| Other Expenses | - | - | 6.91 Million | 2 Million | 2.03 Million | 1.08 Million |
| Cost and Expenses | 2.07 Billion | 1.99 Billion | 8.3 Billion | 2.13 Billion | 2.08 Billion | 2.05 Billion |
| Operating Income | 439.56 Million | 397 Million | 1.44 Billion | 205.2 Million | 492.12 Million | 406.14 Million |
| Interest Expense | 1.87 Million | 1.56 Million | 4.82 Million | 1.2 Million | 1.21 Million | 1.2 Million |
| Income Tax Expense | 119.16 Million | 108 Million | 447.85 Million | 98.16 Million | 137.2 Million | 115.37 Million |
| Earnings before Tax | 438.44 Million | 397 Million | 1.43 Billion | 198.61 Million | 487.68 Million | 408.28 Million |
| Net Income | 319.27 Million | 289 Million | 988.6 Million | 100.44 Million | 350.47 Million | 292.91 Million |
| Earnings Per Share Basic | 11.11 | 10.06 | - | 3.50 | 12.20 | 10.20 |
| Earnings Per Share Diluted | 11.11 | 10.06 | - | 3.50 | 12.20 | 10.20 |
| Weighted Average Shares Outstanding | 28.72 Million | 28.72 Million | 28.72 Million | 28.72 Million | 28.72 Million | 28.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.72 Million | 28.72 Million | 28.72 Million | 28.72 Million | 28.72 Million | 28.72 Million |
| Gross Margin | 0.42 | 0.42 | 0.40 | 0.39 | 0.42 | 0.42 |
| EBIT Margin | 0.20 | 0.19 | - | 0.11 | 0.19 | 0.17 |
| Profit Margin | 0.13 | 0.12 | 0.10 | 0.04 | 0.14 | 0.12 |
| EBITDA | 497.95 Million | 450.5 Million | - | 263.43 Million | 493.95 Million | 407.32 Million |
| Earnings Before Tax Margin | 0.17 | 0.17 | 0.15 | 0.09 | 0.19 | 0.16 |
8229
1690
TRZ
GFTU
026890
AKI